InspireMD (NYSE:NSPR), developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that two successful live cases featuring CGuard EPS were presented at LINC 2019, which is being held January 21 – 23 in Leipzig, Germany. As quoted in the press release: … Continued
The post InspireMD Announces Two Successful Live Clinical Case Transmissions Featuring CGuard EPS appeared first on Investing News Network.